PathoScan Technologies
PrivateLast Round
Seed
Nov 14, 2024
Total Funding Raised
$167,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PathoScan Technologies operates in Frontier & Industrial Tech and is based in Saskatoon. Its latest recorded funding round was a Seed round in November 2024.
PathoScan Technologies is an agricultural biotechnology company that develops portable, AI-powered diagnostic devices for rapid, on-site crop disease detection.
Sector
Frontier & Industrial Tech
Verticals
Biotechnology, Biotech Equipment, Environmental Monitoring
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PathoScan Technologies Comparables
Compare PathoScan Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SensTek Diagnostics | 70% | |
| Hypercell Technologies | 68% | |
| OptiGene Limited | 67% |
For institutional investors. Book with your work email.
PathoScan Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 14, 2024 | ||||
| Grant | Apr 30, 2024 | ||||
| Pre Seed | Oct 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PathoScan Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SVG Ventures|THRIVE | Seed |
| Ag-West Bio Inc. | Seed |
| Innovation Saskatchewan | Grant |
| Front Row Ventures | Seed |
| Startup TNT | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 252% MoM to 1.1K.
- Dec 9, 2025
Monthly visitors increased 458% MoM.
For institutional investors. Book with your work email.
PathoScan Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PathoScan Technologies's valuation, stock price, and market status.
Is PathoScan Technologies a public or private company?
PathoScan Technologies is a private company.
What is the current stock price of PathoScan Technologies?
PathoScan Technologies is a private company, so its shares have no public market price. Caplight tracks PathoScan Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PathoScan Technologies worth (valuation)?
Valuation information for PathoScan Technologies is not publicly available.
Can I buy PathoScan Technologies stock?
PathoScan Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PathoScan Technologies's last funding round?
PathoScan Technologies's most recent funding round was Seed on November 14, 2024.
Who are the main investors in PathoScan Technologies?
Key investors in PathoScan Technologies include Startup TNT.
Will PathoScan Technologies IPO soon?
No public IPO plans have been announced for PathoScan Technologies.
How can I track PathoScan Technologies secondary market activity?
Caplight tracks bids, offers, and trades in PathoScan Technologies's shares on secondary markets.